Live News EARNINGS H impact Jul 10, 2026, 10:51 AM UTC

Ionis Pharmaceuticals Reaffirms Fiscal 2026 Financial Guidance

Ionis Pharmaceuticals (IONS) reaffirmed its fiscal 2026 financial guidance, leaving unchanged the outlook issued with its first-quarter results, citing a regulatory filing on Friday.

IONS

SQUAWKNEWS Updated Jul 10, 2026, 10:51 AM UTC

Ionis Pharmaceuticals (IONS) reaffirmed its fiscal 2026 financial guidance, leaving unchanged the outlook issued with its first-quarter results, citing a regulatory filing on Friday.